Class ITerminatedVoluntary: Firm initiated
Kedake Inc: food recall F-0695-2025
Kedake Inc of Houston, TX recalled Las Ollas Botana Mix snack, 2lbs, item #1516, # 1056, UPC# 880342001855. Reason: Undeclared Sesame, Soy, Wheat, Yellow No. 5, Yellow No. 6, and Red No. 6. The FDA listed it as Class I in its Enforcement Report dated Apr 16, 2025; distribution: Texas.
Record status as published: Terminated (terminated Jul 10, 2026). openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Las Ollas Botana Mix snack, 2lbs, item #1516, # 1056, UPC# 880342001855
- Product quantity
- 332 bags (2lbs per bag)
- Reason for recall
- Undeclared Sesame, Soy, Wheat, Yellow No. 5, Yellow No. 6, and Red No. 6.
- Codes, lots and dates on the package
- All lots
- Distribution pattern
- Texas
- Recalling firm
- Kedake Inc, Houston, TX
- Classification
- Class I — the FDA uses this class for a situation in which there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Telephone
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Feb 7, 2025 |
| Classified by the FDA | Apr 7, 2025 |
| Published in the Enforcement Report | Apr 16, 2025 |
| Terminated | Jul 10, 2026 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number F-0695-2025 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.